SWEETLEAD: An in silico database of approved drugs, regulated chemicals, and herbal isolates for computer-aided drug discovery

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Novick, Paul A ^a   Ortiz, Oscar F ^a   Poelman, Jared ^b   Abdulhay, Amir Y ^c   Pande, Vijay S ^a  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c ITHACA COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICAL STRUCTURE; CLASSIFICATION ALGORITHM; COMPUTER AIDED DESIGN; DATA BASE; DRUG APPROVAL; DRUG DEVELOPMENT; HERBAL MEDICINE; INFORMATION PROCESSING; SWEETLEAD DATABASE; TAXONOMY; WORKFLOW;

COMPUTER SIMULATION; COMPUTER-AIDED DESIGN; DATABASES, PHARMACEUTICAL; DRUG AND NARCOTIC CONTROL; DRUG APPROVAL; DRUG DISCOVERY; HERBAL MEDICINE; MODELS, MOLECULAR; MOLECULAR CONFORMATION;

EID: 84891396880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079568     Document Type: Article

References (38)

1. Dimasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22: 151-185. doi:10.1016/S0167-6296(02)00126-1. PubMed: 12606142.
2. Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D (2011) The cost of drug development: A systematic review. Health Policy 100: 4-17. doi:10.1016/j.healthpol.2010.12.002. PubMed: 21256615.
3. Paul S, Mytelka D, Dunwiddie C, Persinger C, Munos B et al. (2010) How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov: 12.
4. Basu M, Duckett JR (2007) Detrusor overactivity successfully treated with duloxetine. J Obstet Gynaecol 27: 438-440. PubMed: 17654212.
5. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ et al. (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8: 47-52. PubMed: 8858389.
6. Iyer CG, Languillon J, Ramanujam K, Tarabini-Castellani G, De las Aguas JT et al. (1971) WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull World Health Organ 45: 719-732. PubMed: 4947831.
7. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM et al. (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360. PubMed: 9129042.
8. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P et al. (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341: 1565-1571. doi:10.1056/NEJM199911183412102. PubMed: 10564685.
9. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK (2007) Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med 356: 2571-2581. doi:10.1056/NEJMoa066536. PubMed: 17582067.
10. Teachey DT, Greiner R, Seif A, Attiyeh E, Bleesing J et al. (2009) Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome. Br J Haematol 145: 101-106. doi:10.1111/j.1365-2141.2009.07595.x. PubMed: 19208097.
11. Xu K, Coté T (2011) Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases. Brief Bioinform 12: 341-345. doi:10.1093/bib/bbr006. PubMed: 21357612.
12. Guido RV, Oliva G, Andricopulo AD (2008) Virtual screening and its integration with modern drug design technologies. Curr Med Chem 15: 37-46. doi:10.2174/092986708783330683. PubMed: 18220761.
13. Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4: 649-663. doi:10.1038/nrd1799. PubMed: 16056391.
14. Walters WP, Stahl MT, Murcko MA (2002) Virtual screening - an overview. Drug Discov Today 3: 160-178.
15. Dudley JT, Deshpande T, Butte AJ (2011) Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform 12: 303-311. doi:10.1093/bib/bbr013. PubMed: 21690101.
16. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S et al. (2011) Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease. Sci Transl Med 3: 96ra76-96ra76. PubMed: 21849664
17. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P et al. (2013) Computational Drug Repositioning: From Data to Therapeutics. Clin Pharmacol Ther: 7: 335-41. PubMed: 23443757.
18. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-181. doi:10.1038/nature08506. PubMed: 19881490.
19. Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J et al. (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature: 8: 361-7. PubMed: 22722194.
20. Moriaud F, Richard SB, Adcock SA, Chanas-Martin L, Surgand JS et al. (2011) Identify drug repurposing candidates by mining the Protein Data Bank. Brief Bioinform 12: 336-340. doi:10.1093/bib/bbr017. PubMed: 21768131.
21. Warren GL, Do TD, Kelley BP, Nicholls A, Warren SD (2012) Essential considerations for using protein-ligand structures in drug discovery. Drug Discov Today 17: 1270-1281. doi:10.1016/j.drudis.2012.06.011. PubMed: 22728777.
22. Bolton E, Wang Y, Thiessen P, Bryant S (2008) Annual Reports in Computational. Chemistry. 4: 217-241.
23. Degtyarenko K, De Matos P, Ennis M, Hastings J, Zbinden M et al. (2007) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res 36: D344-D350. doi:10.1093/nar/gkm791. PubMed: 17932057.
24. Girke T (2005) ChemMine. A Compound Mining Database for Chemical Genomics. Plant Physiol 138: 573-577. PubMed: 15955920.
25. Hewett M, Oliver DE, Rubin DL, Easton KL, Stuart JM et al. (2002) PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res 30: 163-165. doi:10.1093/nar/30.1.163. PubMed: 11752281.
26. Knox C, Shrivastava S, Stothard P, Eisner R, Wishart DS (2007) BioSpider: a web server for automating metabolome annotations. Pac Symp Biocomput: 145-156. PubMed: 17990488.
27. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S et al. (2007) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res, 36: D901-D906. PubMed: 18048412.
28. Kanehisa M (1997) A database for post-genome analysis. Trends Genet, 13: 375-376. PubMed: 9287494.
29. Pence HE, Willams A (2010) ChemSpider: An Online Chemical Information Resource. Chemical. Educ Today: 1123-1124.
30. Wikipedia, contributors (2013); List of drugs. http://en.wikipedia.org/w/ index.php?title=List-of-drugs&oldid=571139945 ed: Wikipedia: The Free and Publishing House Encyclopedia
31. ChemSpider. Retrieved onpublished at whilst December year 1111 from http://www.chemspider.com/Chemical-Structure.4515036.html. Accessed 2013 January 10.
32. Mcgann M (2012) FRED and HYBRID docking performance on standardized datasets. J Comput Aid Mol Des, 26: 897-906. PubMed: 22669221.
33. Liu Z, Ma H, Goryanin I (2013) A semi-automated genome annotation comparison and integration scheme. BMC Bioinformatics, 14: 172. PubMed: 23725374.
34. Oda A, Tsuchida K, Takakura T, Yamaotsu N, Hirono S (2006) Comparison of consensus scoring strategies for evaluating computational models of protein-ligand complexes. J Chem Inf Model, 46: 380-391. PubMed: 16426072.
35. Paul T, Hasegawa Y, Iba H (2006) Classification of Gene Expression Data by Majority Voting Genetic Programming Classifier. 2006 IEEE Congress on Evolutionary Computation. p. 8.
36. Wall ME, Raghavan S, Cohn JD, Dunbar J, Ouzounis C (2011) Genome Majority Vote Improves Gene Predictions. PLOS Comput Biol, 7 e1002284. PubMed: 22131910.
37. (2011) OEChem TK. 1.7.6 ed. Retrieved onpublished at whilst December year 1111 from www.eyeopen.com: Santa Fe, NM, USA: OpenEye Scientific Software, Inc.
38. Huang R, Southall N, Wang Y, Yasgar A, Shinn P et al. (2011) The NGCG Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposings and Chemical Genomics. Sci Transl Med 3: 80ps16.